INVESTMENT OPPORTUNITY
Guanine is seeking investments to develop and launch inexpensive, accurate, portable pathogen detection tests with AI diagnosis |
UNMET PATHOGEN DETECTION NEEDS
|
Deaths from pathogens and, in particular, drug resistant pathogens are likely to increase. The world is experiencing:
(1) more drug resistant strains of viruses, bacteria, fungi and protozoa, (2) less available antibiotics that will kill drug resistant strains and there are very few new antibiotics being developed, (3) more travel and migration of infected people, (4) more routes to transmit pathogens to high density populations including air, insects, ticks, food, water, vermin, animals, unprotected sex, shared needles, etc, (5) more elderly, immunocompromised, co-morbidity, and malnourished people whose immune systems are unable to fight infections, (6) an increased use of prescribed medications and drugs-of-abuse that suppress the immune system, (7) lifetime accumulation of chronic pathogens in biofilms such as herpes and Epstein Barr virus, and (8) more rogue laboratories that have greater capability to produce biothreats and terrorist who may obtain virulent pathogens for nefarious uses. |
Source: National Institutes of Health
INVESTOR DECK
|